Inkef is an Amsterdam-based venture capital firm that invests in high-growth European startups across deep tech, software, and life sciences. It typically invests from Series A onward and is known for bringing long-term capital backed by major institutional support. The firm combines a broad European outlook with meaningful depth in healthcare and science-based businesses.

Its healthcare and life sciences activity makes it relevant for neurotech and biotech companies that need growth capital and follow-on capacity rather than just an early angel check. Inkef is not a neurotech-specialist fund, but its long-term orientation and scale can make it a useful partner for science-heavy companies progressing beyond seed. Its backing from a major pension fund reinforces its patient-capital profile.

Geographically, Inkef is focused on the Benelux region and broader Europe. For neurotech, it is most relevant to European companies with a strong healthcare, diagnostics, or therapeutics angle that are ready for institutional scaling capital. It fits better as a growth-oriented European VC than as a narrow neuro-focused first-check investor.